We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
(-13%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$60.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$30.7M |
| 3 |
Biogen
BIIB
|
+$19.7M |
| 4 |
Mastercard
MA
|
+$18.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSRO
TESARO, Inc.
TSRO
|
+$32.8M |
| 2 |
Ecopetrol
EC
|
+$29.1M |
| 3 |
AET
Aetna Inc
AET
|
+$20.2M |
| 4 |
ExxonMobil
XOM
|
+$19.6M |
| 5 |
Amgen
AMGN
|
+$19.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.31% |
| 2 | Technology | 15.37% |
| 3 | Financials | 11.61% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Hasbro
HAS
$12.6B
| – | – |
-5,260
| Closed | -$553K |
|
802
Huntington Ingalls Industries
HII
$11.3B
| – | – |
-1,816
| Closed | -$465K |
|
803
ICU Medical
ICUI
$3.93B
| – | – |
-1,500
| Closed | -$424K |
|
804
InterContinental Hotels
IHG
$23B
| – | – |
-17
| Closed | -$1K |
|
805
ORIX
IX
$44B
| $0 | ﹤0.01% |
+30
| New | +$470 |
|
806
Leidos
LDOS
$14.1B
| – | – |
-8,496
| Closed | -$588K |
|
807
Molina Healthcare
MOH
$10.3B
| – | – |
-5,000
| Closed | -$744K |
|
808
NiSource
NI
$22.4B
| – | – |
-81,380
| Closed | -$2.03M |
|
809
Insperity
NSP
$1.85B
| – | – |
-2,103
| Closed | -$248K |
|
810
OGE Energy
OGE
$10.3B
| – | – |
-6,288
| Closed | -$228K |
|
811
ON Semiconductor
ON
$33.8B
| – | – |
-19,000
| Closed | -$350K |
|
812
Old Republic International
ORI
$10.3B
| – | – |
-22,000
| Closed | -$492K |
|
813
Planet Fitness
PLNT
$4.23B
| – | – |
-3,815
| Closed | -$206K |
|
814
Philip Morris
PM
$301B
| – | – |
-94,278
| Closed | -$7.69M |
|
815
Pinnacle West Capital
PNW
$12.9B
| – | – |
-3,946
| Closed | -$312K |
|
816
Cartesian Therapeutics
RNAC
$232M
| – | – |
-4,767
| Closed | -$2.22M |
|
817
Sabre
SABR
$656M
| – | – |
-160,034
| Closed | -$4.17M |
|
818
Signet Jewelers
SIG
$3.55B
| – | – |
-8,000
| Closed | -$527K |
|
819
Southern Company
SO
$110B
| – | – |
-78,161
| Closed | -$3.41M |
|
820
Upbound Group
UPBD
$1.19B
| – | – |
-236,532
| Closed | -$3.4M |
|
821
United Therapeutics
UTHR
$26.3B
| – | – |
-2,800
| Closed | -$358K |
|
822
WEC Energy
WEC
$37.7B
| – | – |
-28,465
| Closed | -$1.9M |
|
823
Xcel Energy
XEL
$51B
| – | – |
-46,430
| Closed | -$2.19M |
|
824
Zebra Technologies
ZBRA
$12.4B
| – | – |
-23,254
| Closed | -$4.11M |
|
|
JOYY
825
JOYY Inc
JOYY
$3.73B
| – | – |
-4,000
| Closed | -$300K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2018 Portfolio in Review
As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
- Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
- Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
- Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
- Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
- Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
- Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.
Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.